5VM
5AM Venture Management Portfolio holdings
AUM
$260M
This Quarter Return
+33.63%
1 Year Return
+3.76%
3 Year Return
+144.87%
5 Year Return
+32.61%
10 Year Return
–
AUM
$457M
AUM Growth
+$457M
(+41%)
Cap. Flow
+$74.3M
Cap. Flow
% of AUM
16.27%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
1
Reduced
2
Closed
–
Top Buys
| 1 |
AKUS
Akouos, Inc. Common Stock
AKUS
|
$104M |
| 2 |
scPharmaceuticals
SCPH
|
$4.25M |
Top Sells
| 1 |
Aprea Therapeutics
APRE
|
$24.8M |
| 2 |
Crinetics Pharmaceuticals
CRNX
|
$8.76M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKUS
1
DELISTED
Akouos, Inc. Common Stock
AKUS
| $104M | 22.69% |
+4,605,784
| New | +$104M |
|
|
2
Aprea Therapeutics
APRE
$9.15M
| $85.8M | 18.79% |
2,212,654
-640,000
| -22% | -$24.8M |
|
3
Q32 Bio
QTTB
$20.9M
| $84.1M | 18.42% |
5,535,919
| – | – |
|
4
IDEAYA Biosciences
IDYA
$2.23B
| $49.2M | 10.78% |
3,463,066
| – | – |
|
5
Cabaletta Bio
CABA
$133M
| $40.9M | 8.95% |
3,669,263
| – | – |
|
6
Arvinas
ARVN
$580M
| $33.5M | 7.35% |
1,000,000
| – | – |
|
|
7
scPharmaceuticals
SCPH
$296M
| $28.2M | 6.18% |
3,831,474
+578,034
| +18% | +$4.25M |
|
|
8
Crinetics Pharmaceuticals
CRNX
$3.14B
| $23.9M | 5.23% |
1,362,286
-500,000
| -27% | -$8.76M |
|
9
Cidara Therapeutics
CDTX
$1.62B
| $7.4M | 1.62% |
2,006,511
| – | – |
|